Related Experiment Videos
Early tumor effect on splenic Th lymphocytes in mice
J A Segura1, L G Barbero, J Márquez
1Departamento de Bioquímica y Biología Molecular, Facultad de Ciencias, Universidad de Málaga, Spain.
FEBS Letters
|September 26, 1997
Summary
Tumors evade the immune system by altering immune cells. Early tumor growth in mice reduced T-helper lymphocytes and increased macrophages, indicating active immune modulation by tumor-secreted factors.
Area of Science:
- Immunology
- Cancer Biology
- Tumor Microenvironment
Background:
- Tumors possess mechanisms to evade host immune surveillance.
- Understanding early immune system alterations is crucial for cancer research.
Purpose of the Study:
- To investigate early changes in the host immune system following tumor cell inoculation.
- To identify tumor-secreted factors involved in immune modulation.
Main Methods:
- Ehrlich ascites tumor cells were inoculated into mice.
- Flow cytometry was used to analyze splenic lymphocyte populations (Th lymphocytes, CD4+ lymphocytes, IFN-gamma expression).
- Macrophage frequency and numbers were assessed; TGF-beta precursors were detected in tumor cells and ascitic fluid.
Main Results:
- Splenic T-helper lymphocyte frequencies decreased significantly within two days post-inoculation.
- Increased frequency of splenic CD4+ lymphocytes expressing IFN-gamma, without a change in total numbers, suggested no net Th1 response.
- Splenic macrophage frequency and cell numbers increased after four days.
- Similar immune alterations were observed with cell-free ascitic fluid, and TGF-beta precursors were found in tumor cells and fluid.
Conclusions:
- Tumor cells actively interact with and modulate the host immune system.
- Tumor-secreted factors, potentially including TGF-beta precursors, play a role in these early immune alterations.
- These findings highlight the complex interplay between tumors and the immune system during early tumorigenesis.